SecBot SecBot
424B5 ·Filed Sep 8, 2026

SNN

SMITH & NEPHEW PLC
NEUTRAL
Impact 4/10
Horizonweeks Processed2mo ago SEC0000950103-26-013643
Notable filing: 424B5
Actionable Insight • Neutral

This is a liability management transaction, not a fundamental change. Monitor the tender offer results (expires Sept 15, 2026) for the final take-up rate on the 2030 notes. The new notes will trade based on SNN's credit quality, not equity fundamentals. No immediate read-through for SNN common stock.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$27.87
T+0 close · Sep 8, 2026 · via day close
Latest settled
−3.59%
T+20 · $26.87 · next T+60 in 15d
Vs SPY
−5.30%
α at T+20
Latest observation
+13.68%
T+48 · FF3 residual α
  1. T+0 · Sep 8 $27.87entry
  2. T+1 · 2mo ago −0.25%α +0.21% · $27.80
  3. T+5 · 2mo ago +0.50%α +1.62% · $28.01
  4. T+20 · 6w ago −3.59%α −5.30% · $26.87
  5. T+49 · todayOpen
  6. T+60 · in 15d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Smith & Nephew is issuing an undisclosed amount of 10-year senior unsecured notes due 2036, with proceeds intended to fund a concurrent tender offer for up to $250M of its 2.032% Senior Notes due 2030 (of which $900M is outstanding). The offering is a debt refinancing, replacing near-term maturities with longer-dated paper, and does not change the company's overall leverage profile or equity value. The filing is a routine capital markets transaction with no material impact on SNN common stock fundamentals.

Key Facts

  • Smith & Nephew is offering an undisclosed amount of % Notes due 2036 under a shelf registration.
  • Net proceeds will fund purchases of up to $250M of its 2.032% Senior Notes due 2030 via a concurrent tender offer expiring September 15, 2026.
  • The 2030 Tender Offer Notes have $900M aggregate principal outstanding; the tender is capped at $250M.
  • The new notes are unsecured, unsubordinated, and rank equally with existing unsecured debt.
  • Application will be made to list the notes on the NYSE.
  • H1 2026 revenue was $3,097M (up 4.6% YoY from $2,961M); operating profit was $448M (up 4.4% YoY from $429M).
  • Cash and cash equivalents stood at $750M as of June 27, 2026; total debt was $3,588M.
  • The offering is not conditioned on the tender offer, but the tender offer requires this offering to close.

Financial Impact

Debt refinancing, new 10-year notes replace up to $250M of 2030 notes (4-year maturity extension). No change in total debt or equity; net leverage unchanged.

debt maturity profileinterest expense

Risk Factors

  • Tender offer may not be completed as planned, leaving proceeds used for general corporate purposes instead of debt reduction.
  • Change of Control Repurchase Event clause requires 101% repurchase if both a change of control and ratings downgrade to below investment grade occur.
  • Cross-default provision triggers at $50M threshold on other indebtedness.

Market Snapshot

Exchange
OTC
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
46% bullish (24 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B5 Filing (Primary)0000950103-26-013643
Document: 0000950103-26-013643-index-headers.html0000950103-26-013643
Document: 0000950103-26-013643-index.html0000950103-26-013643
Document: 0000950103-26-013643.txt0000950103-26-013643

Track record

42 reports on SNN

Performance horizon

6 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +8.02% at T+20 after the Jun 30, 2026 report. 8 of 9 went positive at some point.

Filters
  1. Nov 12, 20264d ago 6-K Neutral 1/10 Entry $31.00 Now $30.97 −0.10% settles Nov 19
  2. Nov 4, 202612d ago 6-K Bearish 6/10 No price data
  3. Nov 4, 202612d ago 6-K Bearish 6/10 Entry $32.46 to $31.04 Now $30.97 +4.59% ▲ +4.37% +3.46% vs SPY
  4. Nov 2, 202614d ago 6-K Neutral 4/10 Entry $30.24 to $31.05 Now $30.97 +2.41% ▲ +2.68% +2.60% vs SPY
  5. Oct 22, 202625d ago 6-K Neutral 2/10 Entry $30.88 to $30.22 Now $30.97 +0.29% ▼ −2.14% −2.84% vs SPY
  6. Oct 8, 20265w ago 6-K Neutral 2/10 Entry $26.96 to $29.09 Now $30.97 +14.87% ▲ +7.90% +8.18% vs SPY
  7. Oct 1, 20266w ago 6-K Neutral 2/10 Entry $26.58 to $26.96 Now $30.97 +16.52% ▲ +1.43% +0.13% vs SPY
  8. Oct 1, 20266w ago 6-K Neutral 2/10 Entry $26.58 to $26.96 Now $30.97 +16.52% ▲ +1.43% +0.13% vs SPY
  9. Sep 23, 20267w ago Press Release Neutral 3/10 Entry $26.82 to $26.96 Now $30.97 +15.47% ▲ +0.52% +1.20% vs SPY
  10. Sep 23, 20267w ago Press Release Neutral 3/10 Entry $26.82 to $26.96 Now $30.97 +15.47% ▲ +0.52% +1.20% vs SPY
Showing 10 of 42

US Market Status

Market Closed · Opens Wed (11h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 9, 2026